Global Reach Health – Page 91 – Global Reach Health

November 26, 2018

New Dosage Form of Actemra Approved

November 26, 2018 – The U.S. FDA has approved the ACTPenTM 162mg/0.9mL prefilled auto-injector, a new dosage form of Genentech's Actemra® (tocilizumab). It is indicated for the treatment of certain patients who have rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (PJIA), or systemic juvenile idiopathic arthritis (SJIA).

November 17, 2018

Brand Medications with Generic Alternatives Anticipated to be Approved in January

Nuvaring (etonogestrel-ethinyl estradiol) – for birth control
Zyclara (imiquimod cream 3.75%) – for skin disorders

November 16, 2018

Temixys Approved to Treat HIV

November 16, 2018 – The U.S. FDA has approved TemixysTM (300mg lamivudine/300mg tenofovir disoproxil fumarate), manufactured by Celltrion, for use in combination with other antiretroviral agents to treat HIV-1 infection in adults and pediatric patients who weigh at least 35kg (77 pounds).